These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21368101)

  • 1. Quantitative analysis of the CD4 T-cell repertoire specific to therapeutic antibodies in healthy donors.
    Delluc S; Ravot G; Maillere B
    FASEB J; 2011 Jun; 25(6):2040-8. PubMed ID: 21368101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R.
    Sirven P; Castelli FA; Probst A; Szely N; Maillere B
    Mol Immunol; 2009 Apr; 46(7):1481-7. PubMed ID: 19193441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
    Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
    Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
    Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allorecognition of HLA-DR and -DQ transfectants by human CD45RA and CD45R0 CD4 T cells: repertoire analysis and activation requirements.
    Merkenschlager M; Ikeda H; Wilkinson D; Beverly PC; Trowsdale J; Fisher AG; Altmann DM
    Eur J Immunol; 1991 Jan; 21(1):79-88. PubMed ID: 1671359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrations in the primary T-cell receptor repertoire as a predisposition for synovial inflammation in rheumatoid arthritis.
    Yang H; Rittner H; Weyand CM; Goronzy JJ
    J Investig Med; 1999 May; 47(5):236-45. PubMed ID: 10361384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.
    Campi G; Crosti M; Consogno G; Facchinetti V; Conti-Fine BM; Longhi R; Casorati G; Dellabona P; Protti MP
    Cancer Res; 2003 Dec; 63(23):8481-6. PubMed ID: 14679013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors.
    Ito Y; Nieda M; Uchigata Y; Nishimura M; Tokunaga K; Kuwata S; Obata F; Tadokoro K; Hirata Y; Omori Y
    J Immunol; 1993 Nov; 151(10):5770-6. PubMed ID: 8228261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors.
    Li Y; Zhu Y; Zhou L; Fang Y; Huang L; Ren L; Peng Y; Li Y; Yang F; Xie D; Tang W; Zhang N; Zhong Q; Lai X
    Immunobiology; 2011 Aug; 216(8):947-60. PubMed ID: 21281984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay.
    Schultz HS; Reedtz-Runge SL; Bäckström BT; Lamberth K; Pedersen CR; Kvarnhammar AM;
    PLoS One; 2017; 12(5):e0178544. PubMed ID: 28562666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
    Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
    J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell alloresponses against HLA-DQ and -DR products involve multiple epitopes on the CD4 molecule. Distinct mechanisms contribute to the inhibition of HLA class II-dependent and -independent T cell responses by antibodies to CD4.
    Merkenschlager M; Altmann DM; Ikeda H
    J Immunol; 1990 Nov; 145(10):3181-7. PubMed ID: 1699999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
    van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
    J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
    Goronzy JJ; Xie C; Hu W; Lundy SK; Weyand CM
    J Immunol; 1993 Jul; 151(2):825-36. PubMed ID: 8335912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
    Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
    Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR.
    Sun Y; Song M; Jäger E; Schwer C; Stevanovic S; Flindt S; Karbach J; Nguyen XD; Schadendorf D; Cichutek K
    Clin Cancer Res; 2008 Jul; 14(13):4306-15. PubMed ID: 18594014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprevalence of the CD4+ T-cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively.
    Castelli FA; Houitte D; Munier G; Szely N; Lecoq A; Briand JP; Muller S; Maillere B
    Eur J Immunol; 2008 Oct; 38(10):2821-31. PubMed ID: 18828138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles.
    Chapman A; Stewart SJ; Nepom GT; Green WF; Crowe D; Thomas JW; Miller GG
    J Immunol; 1996 Dec; 157(11):4771-80. PubMed ID: 8943378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.